These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19557727)

  • 1. Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancer.
    Planey CR; Welch EB; Xu L; Chakravarthy AB; Gatenby JC; Freehardt D; Mayer I; Meszeoly I; Kelley M; Means-Powell J; Gore JC; Yankeelov TE
    J Magn Reson Imaging; 2009 Jul; 30(1):121-34. PubMed ID: 19557727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
    Jena A; Mehta SB; Taneja S
    J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
    Li X; Welch EB; Arlinghaus LR; Chakravarthy AB; Xu L; Farley J; Loveless ME; Mayer IA; Kelley MC; Meszoely IM; Means-Powell JA; Abramson VG; Grau AM; Gore JC; Yankeelov TE
    Phys Med Biol; 2011 Sep; 56(17):5753-69. PubMed ID: 21841212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
    Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
    Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the pharmacokinetic parameter ratios in DCE-MRI using the reference region model.
    Lee J; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2012 Jan; 30(1):26-35. PubMed ID: 22071409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.
    Yankeelov TE; Luci JJ; Lepage M; Li R; Debusk L; Lin PC; Price RR; Gore JC
    Magn Reson Imaging; 2005 May; 23(4):519-29. PubMed ID: 15919597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.
    Larsson C; Kleppestø M; Rasmussen I; Salo R; Vardal J; Brandal P; Bjørnerud A
    J Magn Reson Imaging; 2013 Apr; 37(4):818-29. PubMed ID: 23086710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of analytical and numerical analysis of the reference region model for DCE-MRI.
    Lee J; Cárdenas-Rodríguez J; Pagel MD; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2014 Sep; 32(7):845-53. PubMed ID: 24925838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital reference object toolkit of breast DCE MRI for quantitative evaluation of image reconstruction and analysis methods.
    Bae J; Tan Z; Solomon E; Huang Z; Heacock L; Moy L; Knoll F; Kim SG
    Magn Reson Med; 2024 Oct; 92(4):1728-1742. PubMed ID: 38775077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?
    Wake N; Chandarana H; Rusinek H; Fujimoto K; Moy L; Sodickson DK; Kim SG
    Magn Reson Imaging; 2018 Oct; 52():16-23. PubMed ID: 29777820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data.
    Heisen M; Fan X; Buurman J; van Riel NA; Karczmar GS; ter Haar Romeny BM
    Magn Reson Med; 2010 Mar; 63(3):811-6. PubMed ID: 20187187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic modeling of dynamic contrast-enhanced MRI using a reference region and input function tail.
    Ahmed Z; Levesque IR
    Magn Reson Med; 2020 Jan; 83(1):286-298. PubMed ID: 31393033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic Analysis of Enhancement-Constrained Acceleration (ECA) reconstruction-based high temporal resolution breast DCE-MRI.
    Ren Z; Easley TO; Pineda FD; Guo X; Barber RF; Karczmar GS
    PLoS One; 2023; 18(6):e0286123. PubMed ID: 37319275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.